These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 29412640)

  • 1. Discovery of Selective RNA-Binding Small Molecules by Affinity-Selection Mass Spectrometry.
    Rizvi NF; Howe JA; Nahvi A; Klein DJ; Fischmann TO; Kim HY; McCoy MA; Walker SS; Hruza A; Richards MP; Chamberlin C; Saradjian P; Butko MT; Mercado G; Burchard J; Strickland C; Dandliker PJ; Smith GF; Nickbarg EB
    ACS Chem Biol; 2018 Mar; 13(3):820-831. PubMed ID: 29412640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and Development of an Escherichia coli Riboflavin Pathway Phenotypic Screen Hit as a Small-Molecule Ligand of the Flavin Mononucleotide Riboswitch.
    Balibar CJ; Villafania A; Barbieri CM; Murgolo N; Roemer T; Wang H; Howe JA
    Methods Mol Biol; 2018; 1787():19-40. PubMed ID: 29736707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atomic resolution mechanistic studies of ribocil: A highly selective unnatural ligand mimic of the E. coli FMN riboswitch.
    Howe JA; Xiao L; Fischmann TO; Wang H; Tang H; Villafania A; Zhang R; Barbieri CM; Roemer T
    RNA Biol; 2016 Oct; 13(10):946-954. PubMed ID: 27485612
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective small-molecule inhibition of an RNA structural element.
    Howe JA; Wang H; Fischmann TO; Balibar CJ; Xiao L; Galgoci AM; Malinverni JC; Mayhood T; Villafania A; Nahvi A; Murgolo N; Barbieri CM; Mann PA; Carr D; Xia E; Zuck P; Riley D; Painter RE; Walker SS; Sherborne B; de Jesus R; Pan W; Plotkin MA; Wu J; Rindgen D; Cummings J; Garlisi CG; Zhang R; Sheth PR; Gill CJ; Tang H; Roemer T
    Nature; 2015 Oct; 526(7575):672-7. PubMed ID: 26416753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA-ALIS: Methodology for screening soluble RNAs as small molecule targets using ALIS affinity-selection mass spectrometry.
    Rizvi NF; Nickbarg EB
    Methods; 2019 Sep; 167():28-38. PubMed ID: 31059829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-Targeting Small-Molecule Inhibitors of the Staphylococcus aureus FMN Riboswitch Disrupt Riboflavin Homeostasis in an Infectious Setting.
    Wang H; Mann PA; Xiao L; Gill C; Galgoci AM; Howe JA; Villafania A; Barbieri CM; Malinverni JC; Sher X; Mayhood T; McCurry MD; Murgolo N; Flattery A; Mack M; Roemer T
    Cell Chem Biol; 2017 May; 24(5):576-588.e6. PubMed ID: 28434876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting RNA with Small Molecules: Identification of Selective, RNA-Binding Small Molecules Occupying Drug-Like Chemical Space.
    Rizvi NF; Santa Maria JP; Nahvi A; Klappenbach J; Klein DJ; Curran PJ; Richards MP; Chamberlin C; Saradjian P; Burchard J; Aguilar R; Lee JT; Dandliker PJ; Smith GF; Kutchukian P; Nickbarg EB
    SLAS Discov; 2020 Apr; 25(4):384-396. PubMed ID: 31701793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into the interactions of flavin mononucleotide (FMN) and riboflavin with FMN riboswitch: a molecular dynamics simulation study.
    Wakchaure PD; Jana K; Ganguly B
    J Biomol Struct Dyn; 2020 Aug; 38(13):3856-3866. PubMed ID: 31498025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-Activity Relationship of Flavin Analogues That Target the Flavin Mononucleotide Riboswitch.
    Vicens Q; Mondragón E; Reyes FE; Coish P; Aristoff P; Berman J; Kaur H; Kells KW; Wickens P; Wilson J; Gadwood RC; Schostarez HJ; Suto RK; Blount KF; Batey RT
    ACS Chem Biol; 2018 Oct; 13(10):2908-2919. PubMed ID: 30107111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integration of Affinity Selection-Mass Spectrometry and Functional Cell-Based Assays to Rapidly Triage Druggable Target Space within the NF-κB Pathway.
    Kutilek VD; Andrews CL; Richards MP; Xu Z; Sun T; Chen Y; Hashke A; Smotrov N; Fernandez R; Nickbarg EB; Chamberlin C; Sauvagnat B; Curran PJ; Boinay R; Saradjian P; Allen SJ; Byrne N; Elsen NL; Ford RE; Hall DL; Kornienko M; Rickert KW; Sharma S; Shipman JM; Lumb KJ; Coleman K; Dandliker PJ; Kariv I; Beutel B
    J Biomol Screen; 2016 Jul; 21(6):608-19. PubMed ID: 26969322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Affinity-Based Profiling of the Flavin Mononucleotide Riboswitch.
    Crielaard S; Maassen R; Vosman T; Rempkens I; Velema WA
    J Am Chem Soc; 2022 Jun; 144(23):10462-10470. PubMed ID: 35666649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expanding the DNA-encoded library toolbox: identifying small molecules targeting RNA.
    Chen Q; Li Y; Lin C; Chen L; Luo H; Xia S; Liu C; Cheng X; Liu C; Li J; Dou D
    Nucleic Acids Res; 2022 Jul; 50(12):e67. PubMed ID: 35288754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescent Ligand Equilibrium Displacement: A High-Throughput Method for Identification of FMN Riboswitch-Binding Small Molecules.
    Tidwell ED; Kilde IR; Leskaj S; Koutmos M
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystallographic analysis of TPP riboswitch binding by small-molecule ligands discovered through fragment-based drug discovery approaches.
    Warner KD; Ferré-D'Amaré AR
    Methods Enzymol; 2014; 549():221-33. PubMed ID: 25432751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preparation of modified long-mer RNAs and analysis of FMN binding to the ypaA aptamer from B. subtilis.
    Frommer J; Hieronymus R; Selvi Arunachalam T; Heeren S; Jenckel M; Strahl A; Appel B; Müller S
    RNA Biol; 2014; 11(5):609-23. PubMed ID: 24755604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Revolution of Small Molecule Drug Discovery by Affinity Selection-Mass Spectrometry Technology.
    Motoyaji T
    Chem Pharm Bull (Tokyo); 2020; 68(3):191-193. PubMed ID: 32115525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantum Mechanics Helps Uncover Atypical Recognition Features in the Flavin Mononucleotide Riboswitch.
    Deb I; Wong H; Tacubao C; Frank AT
    J Phys Chem B; 2021 Aug; 125(30):8342-8350. PubMed ID: 34310879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
    Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
    Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating fragment-based drug discovery for biological RNAs: lead fragments bind and remodel the TPP riboswitch specifically.
    Warner KD; Homan P; Weeks KM; Smith AG; Abell C; Ferré-D'Amaré AR
    Chem Biol; 2014 May; 21(5):591-5. PubMed ID: 24768306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Affinity selection-mass spectrometry for the discovery of pharmacologically active compounds from combinatorial libraries and natural products.
    Muchiri RN; van Breemen RB
    J Mass Spectrom; 2021; 56(5):e4647. PubMed ID: 32955158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.